Cardiology and Cardiovascular Medicine

ISSN: 2572-9292
Impact Factor: 1.5
PubMed NLM: 101721428
Index Copernicus Value: 70.05

Editor In Chief

Andreas Synetos

Andreas Synetos

First Department of Cardiology 
University of Athens, Medical School
Paleo Psychico
Athens, Greece



Role of Aripiprazole in the Treatment of Cardiovascular Disease

The known cause of cardiac conduction disturbances predicts the cardiovascular side effects inducing severe arrhythmia by the use of atypical antipsychotic i.e. Aripiprazole The efficacies in co-morbidities absolutely risk the warning detection of sudden death cause with major mental disorders interacting the mechanism in the predisposing malignancy factors. Therefore, we believe to improve dose-dependent inhibition coding the life-threatening ventricular tachycardia based on cardiac toxicity issue regulate the evaluation of testing drug criteria in clinical practice.


Hassah Batool Iftikhar, Hassam Ali

Abstract PDF Full Text

Submit Article to Us


Fortune Journals follows COPE Guidelines


Fortune Journals submits each review to Publons